23andMe Appoints Three New Independent Directors to Board - Cardlytics (NASDAQ:CDLX), Ansys (NASDAQ:ANSS)
In an announcement from GLOBE NEWSWIRE on October 29th in Sunnyvale California in 2024,"23andMe" a well known company focusing on genetics and preventive health services welcomed Andre Fernandez,Jim Frankola and Mark Jensen as new independent members, to their Board of Directors.Their appointment became official on October 28th of the year. Mr Fernandez leads the Audit Committee and Mr Jensen heads the Compensation Committee; they are both part of the Board of Directors responsibilities along with Mr Frankolas role in these teams.Mr Jensen also acts as the Lead Independent Director, within the Boards scope of work.
The board will now feature the three selected directors alongside Anne Wojickci who serves as the companys CEO and Board Chairperson.
Mr.Jensen shared the enthusiasm of the board members for working with Anne Wojcicki and the Companys management team to prepare 23andMe for the future ahead with care and attention to detail.He highlighted the significance of 23andMes brand. Reaffirmed the Companys steadfast commitment to its mission of empowering individuals to access and leverage genomic information efficiently.The team is enthusiastic about getting down to work and implementing strategies that will lead the Company towards lasting success, in the future.
"I am delighted to welcome these three directors to the 23andMe Board and look forward to working closely with them " Ms.Wojckickis expressed with enthusiasm.
Mr.Jensen brings a deal of financial and corporate governance knowledge from his experience as a consultant and board member in technology companies.Before retiring in 2012 he had roles at Deloitte & Touche LLP such as U.S Managing Partner for Audit and Enterprise Risk Services in the Technology Industry and U.S Managing Partner for the Venture Capital Services Group.Prior to joining Deloitte Mr.Jensen was the Chief Financial Officer at Redleaf Group. Also held a leadership position, at the accounting firm Arthur Andersen LLP. He used to manage the Silicon Valley Office and lead the Global Technology Industry Practice for some time in the past. Presently Mr.Jensen is actively engaged with the Board of Directors. Serves as the Chair of the Audit Committee, at Lattice Semiconductor Corporation (LSCC).
Mr Fernandez has a background in leadership across different sectors and currently holds a key position as the Chief Financial Officer at WeWork Inc. following previous roles as Executive Vice President and CFO at NCR Corporation and President/CEO of CBS Radio Inc.. He is also actively involved in the Board of Directors and Audit Committee, at Cardlytics Inc (CDLX).
Mr.Frankola is a figure in the tech industry with a rich background in leadership and consulting roles.He notably served as the Chief Financial Officer and a key advisor at Cloudera Inc. a company specializing in enterprise data cloud services.Prior to his time at Cloudera Inc. he held the CFO position at Yodlee Inc., known for its data aggregation and analytics platform.Additionally he was part of Ariba Inc., a leading provider of procurement and supply chain management technology.Currently Mr.Frankola is actively involved as a member of the Board of Directors. Serves as the Chair of the Audit Committee, at Ansys Inc. Mr Frankola is a member of the Board of Directors and the Audit Committee at Skillsoft Corp (SKIL). Additionally he provides guidance to intelligence firms such, as Vectara and Narada.
How about we have a discussion, on 23andMe?
This press release discusses projections in relation to past laws such as the Securities Act of 1933 and the Securities Exchange Act of 1934.All information in this press release except, for historical facts comprises forward looking statements. Not all expressions that suggest future outcomes include terms like "believes," "forecasts," "calculates," "organizes,". Others listed here to indicate intentions, for the future. These predictions reflect 23andMes outlook and future estimations basedon assumptions in place at the moment.It is important to note that there is no guarantee that 23andMe will achieve all the goals and expectations outlined in these predictions.There are risks and uncertainties associated with these statements some of which are, beyond 23andMes control.These factors could result in outcomes or performance deviating significantly from what is indicated in the statements. The looking statements in this document are also affected by risks and uncertainties that are regularly outlined in the Companys filings with the Securities and Exchange Commission including risks identified in the "Risk Factors" section of the latest Annual Report filed as Form 10 K as well, as updates provided in the Companys Quarterly Reports (Form 10 Q) and Current Reports (Form 8 K). The information shared in this press release is current as of the date stated. The Company is not obligated to make updates unless legally required or in response, to new information or developments.
Market information sourced from the Benzinga API.